Ernexa Therapeutics Inc. Stock Issued During Period, Value, Restricted Stock Award, Gross
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Ernexa Therapeutics Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2022-12-31 was $0.00.
- Ernexa Therapeutics Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2022-09-30 was $0.00.
- Ernexa Therapeutics Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2022-06-30 was -$5.00K.
- Ernexa Therapeutics Inc. stock issued during period, value, restricted stock award, gross for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Ernexa Therapeutics Inc. stock issued during period, value, restricted stock award, gross for fiscal 2022 was -$5.00K.
- Ernexa Therapeutics Inc. stock issued during period, value, restricted stock award, gross for fiscal 2014 was -$33.00K.
- Ernexa Therapeutics Inc. stock issued during period, value, restricted stock award, gross for fiscal 2013 was -$16.00K.
- Ernexa Therapeutics Inc. stock issued during period, value, restricted stock award, gross for fiscal 2012 was -$2.00K.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 3 month | Stock Issued During Period, Value, Restricted Stock Award, Gross 12 month |
|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$5.00K 10-K · filed 2024-03-14 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$5.00K 10-Q · filed 2023-08-11 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | |
| 2021-03-31 | $249.91K 10-Q · filed 2021-05-17 | |
| 2014-12-31 | -$33.00K 10-K · filed 2016-03-15 | |
| 2013-12-31 | -$16.00K 10-K · filed 2015-03-27 | |
| 2012-12-31 | -$2.00K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |